Bridge-It trial—a step towards better contraception services
At the 4-month follow-up, use of effective (hormonal or intrauterine) contraception (primary outcome measure) was 20·1% higher (95% CI 5·2–35·0) in the intervention group (mean 58·4%, 48·6–68·2) than the control group (mean 40·5%, 29·7–51·3; p=0·011).1 Of 636 participants, 4-month follow-up data wer...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 2020-11, Vol.396 (10262), p.1536-1537 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1537 |
|---|---|
| container_issue | 10262 |
| container_start_page | 1536 |
| container_title | The Lancet (British edition) |
| container_volume | 396 |
| creator | Marston, Cicely Sowemimo, Annabel |
| description | At the 4-month follow-up, use of effective (hormonal or intrauterine) contraception (primary outcome measure) was 20·1% higher (95% CI 5·2–35·0) in the intervention group (mean 58·4%, 48·6–68·2) than the control group (mean 40·5%, 29·7–51·3; p=0·011).1 Of 636 participants, 4-month follow-up data were available for 406 (64%) women: 198 (63%) of 315 in the intervention group versus 208 (65%) of 318 in the control group. [...]providing the progestogen-only pill in a convenient way would most likely increase uptake, particularly because the method is controlled by the user and is easy to start and stop (25% of those in the intervention group stopped using the progestogen-only pill because of side-effects).1 Details about the experiences of diverse social groups are largely absent from the trial report; ethnicity and parity are mentioned briefly without explanation. Researchers, policy makers, and service providers should work with communities to identify and codesign more interventions to meet people's needs.6 Future efforts need to include the voices of people who use and those who do not use existing services, and take an intersectional approach to identify and address contraceptive needs that are likely to differ depending on characteristics such as age, relationship type, gender identity, disability, cultural background, employment status, and the ability to attend clinics. |
| doi_str_mv | 10.1016/S0140-6736(20)32395-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2460999385</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673620323953</els_id><sourcerecordid>2460999385</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3033-e880ce8be1b94a2cb381592fb32f333b12e0f49f3e9a170dcda93c029e28b51b3</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EoqXwCaBIbMoiYHuSNN6AoOJRCYkFILGzbGeCXLVJsZ0idnwEX8iXkD7ogg2r2Zy5c-cQcsjoKaMsO3ukLKFxNoCsz-kJcBBpDFuky5JBEqfJ4GWbdDdIh-x5P6aUJhlNd0kHgOWCZdAl51fOFq8Yj0IUnFWT788vFfmAsyjU78oVPtIYArrI1FVwyuAs2LqKPLq5Nej3yU6pJh4P1rNHnm-un4Z38f3D7Wh4eR8boAAx5jk1mGtkWiSKGw05SwUvNfASADTjSMtElIBCsQEtTKEEGMoF8lynTEOP9Fe5M1e_NeiDnFpvcDJRFdaNl7x9TAgBedqix3_Qcd24qm23pFoFi0o9kq4o42rvHZZy5uxUuQ_JqFwIlkvBcmFPciqXguVi72id3ugpFputX6MtcLECsNUxt-ikNxYrg4V1aIIsavvPiR9X_oob</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2460046303</pqid></control><display><type>article</type><title>Bridge-It trial—a step towards better contraception services</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Marston, Cicely ; Sowemimo, Annabel</creator><creatorcontrib>Marston, Cicely ; Sowemimo, Annabel</creatorcontrib><description>At the 4-month follow-up, use of effective (hormonal or intrauterine) contraception (primary outcome measure) was 20·1% higher (95% CI 5·2–35·0) in the intervention group (mean 58·4%, 48·6–68·2) than the control group (mean 40·5%, 29·7–51·3; p=0·011).1 Of 636 participants, 4-month follow-up data were available for 406 (64%) women: 198 (63%) of 315 in the intervention group versus 208 (65%) of 318 in the control group. [...]providing the progestogen-only pill in a convenient way would most likely increase uptake, particularly because the method is controlled by the user and is easy to start and stop (25% of those in the intervention group stopped using the progestogen-only pill because of side-effects).1 Details about the experiences of diverse social groups are largely absent from the trial report; ethnicity and parity are mentioned briefly without explanation. Researchers, policy makers, and service providers should work with communities to identify and codesign more interventions to meet people's needs.6 Future efforts need to include the voices of people who use and those who do not use existing services, and take an intersectional approach to identify and address contraceptive needs that are likely to differ depending on characteristics such as age, relationship type, gender identity, disability, cultural background, employment status, and the ability to attend clinics.</description><identifier>ISSN: 0140-6736</identifier><identifier>ISSN: 1474-547X</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(20)32395-3</identifier><identifier>PMID: 33189163</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Birth control ; Co-design ; Contraception ; Contraception, Postcoital ; Contraceptives ; Cross-Over Studies ; Drug stores ; Family Planning Services ; Female ; Gender aspects ; Humans ; Intervention ; Pharmacies ; Pharmacists ; Progestins ; Sex crimes</subject><ispartof>The Lancet (British edition), 2020-11, Vol.396 (10262), p.1536-1537</ispartof><rights>2020 Elsevier Ltd</rights><rights>2020. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3033-e880ce8be1b94a2cb381592fb32f333b12e0f49f3e9a170dcda93c029e28b51b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2460046303?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978,64366,64368,64370,72220</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33189163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marston, Cicely</creatorcontrib><creatorcontrib>Sowemimo, Annabel</creatorcontrib><title>Bridge-It trial—a step towards better contraception services</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>At the 4-month follow-up, use of effective (hormonal or intrauterine) contraception (primary outcome measure) was 20·1% higher (95% CI 5·2–35·0) in the intervention group (mean 58·4%, 48·6–68·2) than the control group (mean 40·5%, 29·7–51·3; p=0·011).1 Of 636 participants, 4-month follow-up data were available for 406 (64%) women: 198 (63%) of 315 in the intervention group versus 208 (65%) of 318 in the control group. [...]providing the progestogen-only pill in a convenient way would most likely increase uptake, particularly because the method is controlled by the user and is easy to start and stop (25% of those in the intervention group stopped using the progestogen-only pill because of side-effects).1 Details about the experiences of diverse social groups are largely absent from the trial report; ethnicity and parity are mentioned briefly without explanation. Researchers, policy makers, and service providers should work with communities to identify and codesign more interventions to meet people's needs.6 Future efforts need to include the voices of people who use and those who do not use existing services, and take an intersectional approach to identify and address contraceptive needs that are likely to differ depending on characteristics such as age, relationship type, gender identity, disability, cultural background, employment status, and the ability to attend clinics.</description><subject>Birth control</subject><subject>Co-design</subject><subject>Contraception</subject><subject>Contraception, Postcoital</subject><subject>Contraceptives</subject><subject>Cross-Over Studies</subject><subject>Drug stores</subject><subject>Family Planning Services</subject><subject>Female</subject><subject>Gender aspects</subject><subject>Humans</subject><subject>Intervention</subject><subject>Pharmacies</subject><subject>Pharmacists</subject><subject>Progestins</subject><subject>Sex crimes</subject><issn>0140-6736</issn><issn>1474-547X</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkMtOwzAQRS0EoqXwCaBIbMoiYHuSNN6AoOJRCYkFILGzbGeCXLVJsZ0idnwEX8iXkD7ogg2r2Zy5c-cQcsjoKaMsO3ukLKFxNoCsz-kJcBBpDFuky5JBEqfJ4GWbdDdIh-x5P6aUJhlNd0kHgOWCZdAl51fOFq8Yj0IUnFWT788vFfmAsyjU78oVPtIYArrI1FVwyuAs2LqKPLq5Nej3yU6pJh4P1rNHnm-un4Z38f3D7Wh4eR8boAAx5jk1mGtkWiSKGw05SwUvNfASADTjSMtElIBCsQEtTKEEGMoF8lynTEOP9Fe5M1e_NeiDnFpvcDJRFdaNl7x9TAgBedqix3_Qcd24qm23pFoFi0o9kq4o42rvHZZy5uxUuQ_JqFwIlkvBcmFPciqXguVi72id3ugpFputX6MtcLECsNUxt-ikNxYrg4V1aIIsavvPiR9X_oob</recordid><startdate>20201114</startdate><enddate>20201114</enddate><creator>Marston, Cicely</creator><creator>Sowemimo, Annabel</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20201114</creationdate><title>Bridge-It trial—a step towards better contraception services</title><author>Marston, Cicely ; Sowemimo, Annabel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3033-e880ce8be1b94a2cb381592fb32f333b12e0f49f3e9a170dcda93c029e28b51b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Birth control</topic><topic>Co-design</topic><topic>Contraception</topic><topic>Contraception, Postcoital</topic><topic>Contraceptives</topic><topic>Cross-Over Studies</topic><topic>Drug stores</topic><topic>Family Planning Services</topic><topic>Female</topic><topic>Gender aspects</topic><topic>Humans</topic><topic>Intervention</topic><topic>Pharmacies</topic><topic>Pharmacists</topic><topic>Progestins</topic><topic>Sex crimes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marston, Cicely</creatorcontrib><creatorcontrib>Sowemimo, Annabel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marston, Cicely</au><au>Sowemimo, Annabel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bridge-It trial—a step towards better contraception services</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2020-11-14</date><risdate>2020</risdate><volume>396</volume><issue>10262</issue><spage>1536</spage><epage>1537</epage><pages>1536-1537</pages><issn>0140-6736</issn><issn>1474-547X</issn><eissn>1474-547X</eissn><abstract>At the 4-month follow-up, use of effective (hormonal or intrauterine) contraception (primary outcome measure) was 20·1% higher (95% CI 5·2–35·0) in the intervention group (mean 58·4%, 48·6–68·2) than the control group (mean 40·5%, 29·7–51·3; p=0·011).1 Of 636 participants, 4-month follow-up data were available for 406 (64%) women: 198 (63%) of 315 in the intervention group versus 208 (65%) of 318 in the control group. [...]providing the progestogen-only pill in a convenient way would most likely increase uptake, particularly because the method is controlled by the user and is easy to start and stop (25% of those in the intervention group stopped using the progestogen-only pill because of side-effects).1 Details about the experiences of diverse social groups are largely absent from the trial report; ethnicity and parity are mentioned briefly without explanation. Researchers, policy makers, and service providers should work with communities to identify and codesign more interventions to meet people's needs.6 Future efforts need to include the voices of people who use and those who do not use existing services, and take an intersectional approach to identify and address contraceptive needs that are likely to differ depending on characteristics such as age, relationship type, gender identity, disability, cultural background, employment status, and the ability to attend clinics.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33189163</pmid><doi>10.1016/S0140-6736(20)32395-3</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 2020-11, Vol.396 (10262), p.1536-1537 |
| issn | 0140-6736 1474-547X 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2460999385 |
| source | MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
| subjects | Birth control Co-design Contraception Contraception, Postcoital Contraceptives Cross-Over Studies Drug stores Family Planning Services Female Gender aspects Humans Intervention Pharmacies Pharmacists Progestins Sex crimes |
| title | Bridge-It trial—a step towards better contraception services |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T19%3A34%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bridge-It%20trial%E2%80%94a%20step%20towards%20better%20contraception%20services&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Marston,%20Cicely&rft.date=2020-11-14&rft.volume=396&rft.issue=10262&rft.spage=1536&rft.epage=1537&rft.pages=1536-1537&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(20)32395-3&rft_dat=%3Cproquest_cross%3E2460999385%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2460046303&rft_id=info:pmid/33189163&rft_els_id=S0140673620323953&rfr_iscdi=true |